Skip to content

Influenza A/B Nucleic Acid Detection (Real-Time Polymerase Chain Reaction)

Published: August 9, 2026Updated: August 16, 2026

This test checks for the genetic material of influenza viruses (A or B) in your respiratory secretions. It helps determine if you have an active flu infection.

Quick summary

["A quick way to confirm flu infection and guide treatment decisions."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
80588-7
Short code
FLUAV M gene Nph Ql NAA+probe
Synonyms
FLUAV M gene Nph Ql NAA+probe
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

How the Test Works

A small sample of your nasal or throat secretions is collected using a swab. The swab is then sent to a lab where special equipment detects the virus’s genetic material using real-time PCR. This process identifies whether influenza A or B is present without needing to grow the virus in a lab.

What to Expect During the Test

You’ll likely have a quick, painless procedure where a healthcare provider inserts a swab into your nose or throat. No special preparation is needed, but avoid eating, drinking, or smoking for 15 minutes before the test if instructed.

When You Might Need This Test

Your doctor may order this test if you have flu-like symptoms (fever, cough, sore throat, body aches) and suspect you have the flu, especially if you’re in a high-risk group (e.g., young children, elderly adults, or those with chronic health conditions).

What the Results Mean

Positive results indicate the presence of influenza virus RNA, confirming an active infection. Negative results mean the virus isn’t detected at the time of testing, but you may still have the flu or it could take time for the virus to be detected.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is critical for early diagnosis of influenza, allowing prompt treatment with antiviral medications that can reduce severity and shorten illness duration. It also supports public health efforts by identifying outbreaks and guiding preventive measures.

Short name

Influenza Virus RNA Test

Frequently asked questions

Why was I asked to take this test?
Your doctor may have recommended this test if you’ve had flu-like symptoms recently, belong to a high-risk group, or are part of a flu surveillance program. It helps confirm whether you have the flu and guides treatment or preventive actions.
What are the possible side effects of this test?
Most people experience mild discomfort or slight irritation from the swab insertion, which usually goes away quickly. Rarely, you might have a slight sore throat or mild nasal congestion, but these are temporary and not serious.
How soon will I get my results?
Results are typically available within 24 to 48 hours, depending on lab processing times. Your doctor will contact you directly with the results once they are ready.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy